After signing up, you'll start to receive regular news updates from us.
NIDDK Renews MetaCore License and Collaborates with GeneGo
Complete the form below to unlock access to ALL audio articles.
GeneGo, Inc. has announced that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), has renewed its MetaCore™ license from GeneGo to continue research collaboration with GeneGo on functional analysis of insulin-resistant diabetes in human and animal models.
"Diabetes and metabolic diseases in general are of great importance for our pharmaceutical and academic customers, and we do our best to stay on top of current science in this area," says Tatiana Nikolskaya, Chief Scientific Officer and President of GeneGo.
"Our collaboration with NIDDK, a leading research institution in metabolic diseases, is a very important part of our development program in this field."
